ATE120373T1 - Nichtspezifisches immunomodulatormittel und verfahren zu dessen herstellung. - Google Patents

Nichtspezifisches immunomodulatormittel und verfahren zu dessen herstellung.

Info

Publication number
ATE120373T1
ATE120373T1 AT90313579T AT90313579T ATE120373T1 AT E120373 T1 ATE120373 T1 AT E120373T1 AT 90313579 T AT90313579 T AT 90313579T AT 90313579 T AT90313579 T AT 90313579T AT E120373 T1 ATE120373 T1 AT E120373T1
Authority
AT
Austria
Prior art keywords
active component
excited state
mixture
production
immunomodulating
Prior art date
Application number
AT90313579T
Other languages
English (en)
Inventor
Edip Prof Dr Bueyuekkoca
Muehendisligi Boeluemue Kimya
Original Assignee
Edip Prof Dr Bueyuekkoca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edip Prof Dr Bueyuekkoca filed Critical Edip Prof Dr Bueyuekkoca
Application granted granted Critical
Publication of ATE120373T1 publication Critical patent/ATE120373T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90313579T 1989-12-13 1990-12-13 Nichtspezifisches immunomodulatormittel und verfahren zu dessen herstellung. ATE120373T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928160A GB8928160D0 (en) 1989-12-13 1989-12-13 A non-specific immunomodulating agent and a process for its production

Publications (1)

Publication Number Publication Date
ATE120373T1 true ATE120373T1 (de) 1995-04-15

Family

ID=10667885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90313579T ATE120373T1 (de) 1989-12-13 1990-12-13 Nichtspezifisches immunomodulatormittel und verfahren zu dessen herstellung.

Country Status (4)

Country Link
EP (1) EP0433067B1 (de)
AT (1) ATE120373T1 (de)
DE (1) DE69018209D1 (de)
GB (1) GB8928160D0 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006099685A1 (en) * 2005-03-24 2006-09-28 Medical Therapies Limited Method for the prophylaxis or treatment of carcinomas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
AU4058789A (en) * 1988-08-29 1990-03-23 Moisey Dobruskin Medicinal drug, method of treatment of human diseases therewith, and method and device for producing and preserving thereof

Also Published As

Publication number Publication date
EP0433067A2 (de) 1991-06-19
DE69018209D1 (de) 1995-05-04
EP0433067A3 (en) 1991-09-25
GB8928160D0 (en) 1990-02-14
EP0433067B1 (de) 1995-03-29

Similar Documents

Publication Publication Date Title
FI893750A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista
AU631068B2 (en) New peptide compounds, process for preparing these and pharmaceutical compositions containing them
ATE94561T1 (de) Substanz fr901228 und deren herstellung.
FI883050A0 (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
HUT47553A (en) Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
HU9302675D0 (en) Process for producing pharmaceutical compositions containing 21-norrapamycin as active agent
EP0590271A3 (en) 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
FI102873B1 (fi) Menetelmä nitroglyseriinipitoisen, hydrofiilisen vesipitoisen pumpattavan sumutteen valmistamiseksi
AU5791190A (en) New peptide derivatives, process for preparing them and pharmaceutical compositions containing them
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
HUT55773A (en) Composition against endoparasites containing 3-hydroxy-benzo-thiophene- or 3-hydroxy-thienopyridine derivatives as active components and process for producing some of the active components
DE3662100D1 (en) Use of solvents in the production of s-triazine derivatives and method for the production of s-triazine derivatives
HUT57205A (en) Process for producing cycloalkano/b/-indol derivatives and pharmaceutical compositions containing them
ATE120373T1 (de) Nichtspezifisches immunomodulatormittel und verfahren zu dessen herstellung.
KR910021361A (ko) 항궤양 물질
FI97226C (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi
DE68913855D1 (de) Verfahren zur Herstellung von dimeren Alkaloiden.
FI903030A0 (fi) Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi
HUT50633A (en) Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives
NO901176D0 (no) Fremgangsmaate for fremstilling av 2,5,6,7-tetranor-4,8-inter-m-fenylen pgi2-derivater.
PT75385B (en) Process for the preparation of aminoglycosides derivatives and of compositions containing these derivatives
FI891866A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten sulfonanilidien valmistamiseksi
ATE97908T1 (de) Platin-(ii)-diamin-komplex, verfahren zur herstellung dieser verbindung, zusammensetzung mit antitumorwirkung, die mindestens eine platin- verbindung enthaelt, und geformte zusammensetzung mit antitumorwirkung.